Attached files
| file | filename |
|---|---|
| 8-K - 8-K - New York REIT Liquidating LLC | v355570_8k.htm |
 |
|
COMMUNICATION FOR BROKER DEALERS AND
FINANCIAL ADVISORS
|
We are writing to inform you that, through today, September 20, 2013, American Realty Capital New York Recovery REIT, Inc. (“ARC NYRR”) has raised $1 billion of its $1.5 billion offering of common stock (not including amounts available under its $250 million distribution reinvestment plan, “DRIP”). As previously announced with respect to its recently filed follow-on offering, ARC NYRR will not raise, in the aggregate, more than the total amount of shares registered for sale in its initial public offering (subject to its right to reallocate shares from its DRIP to the primary offering). ARC NYRR will not launch the follow-on offering if it has raised the amounts contemplated by its initial public offering prior to effectiveness of the follow-on offering. It is currently anticipated that the full amount registered in the initial public offering will be raised prior to the end of the fourth quarter. We will provide you with regular updates regarding the status of ARC NYRR's initial public offering. Your firm has been an important part of the selling group and we appreciate your efforts to support ARC NYRR’s fundraising. |
| Michael Weil Chairman Realty Capital Securities |
R. Lawrence Roth Chief Executive Officer Realty Capital Securities |
Louisa Quarto President Realty Capital Securities |
| Not
For Further Distribution Please do not forward this electronic communication. Copyright (C) 2013 Realty Capital Securities, LLC All rights reserved. Realty Capital Securities, LLC (Member FINRA/SIPC), is the dealer manager for American Realty Capital New York Recovery REIT, Inc. This is neither an offer to sell or a solicitation of an offer to buy the securities described herein. An offering is made only by the prospectus. To obtain a prospectus for any of these offerings, please contact Realty Capital Securities, LLC (Member FINRA/SIPC), Three Copley Place, Suite 3300, Boston, MA 02116, 877-373-2522. |